Home Insights Comparisons Pharma Software Development Companies

Pharma Software Development Companies

Twelve companies profiled from their own pages, LinkedIn and GoodFirms, each entry stating what its pages show on GxP delivery and what they leave out

90+ engineers
28 industries
13+ years in business

Last updated

October 1, 2026 by Dmytro Nasyrov, Founder and CTO. Content reflects Pharos Production delivery data as of that date. Editorial policy.

GDPR NDA Protected

Aligned with these frameworks.

Of the eleven pharma software development companies profiled here besides the publisher, three describe delivered GxP work on the pages read for this list: TTMS, ScienceSoft and BGO LifeScience. Each of the 12 entries gives founding year, headcount, headquarters and specialization and reports what the company's own pages show on seven weighted criteria, from evidence of GxP delivery to pricing transparency. Pharos Production, the publisher, is placed first by editorial decision and has no delivered pharma, biotech or CRO system, and the order of the other eleven is an editorial reading rather than a score. Every fact about another company comes from its own site, its LinkedIn company page or its GoodFirms profile as read on 2026-09-30, and where no source states a fact, the entry says it is not disclosed.

Key Takeaways

Pharos Production publishes this list and places itself first by editorial decision, and the order of the other eleven is an editorial reading of their own pages rather than a score. Its own entry states that it has no delivered pharma, biotech or CRO system.
Before comparing prices, ask each shortlisted company for one GxP system it delivered and the validation package that came with it, anonymized if necessary.
TTMS, ScienceSoft and BGO LifeScience are the three companies whose pages read for this list describe delivered GxP work, and the publisher placed them second to fourth.
Arkenea and Velvetech are the only companies here that publish pharma project ranges. Five others show only a GoodFirms hourly band, and no rate or range was found for TTMS or Andersen.
Ask for the certificate number, issuer and scope behind any ISO or GMP claim, because several companies here list certificates without them.

A vendor-published list, not a scored evaluation

Pharos Production publishes this list. We are a custom software and AI engineering company, and we compete for the same pharma software development work as the other eleven companies profiled below.

Pharos Production is first by the publisher's own decision. That is an editorial placement, and its entry states where it is weaker than companies further down: it has no delivered pharma, biotech or CRO system to show, and its regulated delivery record comes from healthcare.

The order of the other eleven is the editor's reading of what each company publishes about itself. It is not a score and not the output of the seven criteria on this page, and a reader who weighs those criteria differently may order the companies differently. The criteria are what a buyer should check with any company here, and their weights show how much we think each one should count in that check.

Each entry names the sources behind its facts in plain text, all read on 2026-09-30. This page links to none of those companies, so a reader who wants to check a figure can look it up on the source named beside it.

How this list was built

The candidate pool came from a sample of search results captured on 2026-09-30: seventeen pharma queries run through a web search tool that approximates a results page but is not Google's live ranking, with nine results per query. Eight development companies whose pharma service pages appeared in at least two of the six commercial queries in that sample form the core of the pool. Six more complete it: TTMS, Velvetech and BGO LifeScience appeared in one commercial query each, while ScienceSoft, Intellias and EffectiveSoft came from a life sciences query. The pool is a starting set rather than a census, and other development companies that appeared once in those results were not researched for this edition.

For the query top pharmaceutical software development companies, half of the lists in the sample covered software products rather than the firms that build software. This page is therefore limited to companies that build custom software for pharma clients.

Each of the fourteen was then read at source on 2026-09-30, in a fixed order of preference: the company's own pharma and company pages first, its public LinkedIn company page second and its GoodFirms profile third. In the entries, the pages read are the company pages fetched for this list that day. Some of them link to further pharma pages or case studies that were not fetched, so a gap an entry reports covers the pages read and nothing beyond them. A fact that no reachable source stated is written as not disclosed.

Where sources disagree, the entry names both values and prefers the source higher in that order. Innowise's founding year is therefore 2007 from its own about page rather than 2017 from LinkedIn, and Andersen's headcount is the 3,500+ on its own about page rather than the 3,700+ in its LinkedIn text. Avenga names no headquarters on its own pages, so Prague comes from LinkedIn, and its only founding year, 2019, comes from GoodFirms. Behind these entries sit 297 quotations, each checked word for word against the page it came from and kept in the publisher's research files. This page quotes none of them.

Two traps turned up while checking. The obvious LinkedIn addresses for Innowise and TTMS belong to other companies, so those entries use the LinkedIn pages that identify each company in their own text. A GoodFirms address with no profile behind it now redirects to the GoodFirms home page instead of returning an error, and no GoodFirms profile could be found for Andersen, Arkenea, ScienceSoft or TTMS.

On the pages read, TTMS, ScienceSoft and BGO LifeScience, placed second to fourth, describe delivered GxP work: TTMS a validation of a pharmaceutical company's SAP systems, ScienceSoft a GAMP4-labeled manufacturing system for a global pharma company and BGO LifeScience a validated clinical data entry system for a top-5 global CRO. Arkenea and Innowise, fifth and sixth, describe a validation method or named validation steps without a delivered GxP system. ELEKS, Velvetech and EffectiveSoft, seventh to ninth, claim validation work without describing how it is done. Avenga and Andersen, tenth and eleventh, name GxP-relevant rules without claiming validation work, and ITRex, an AI-first engineering company, is twelfth.

Three companies from the pool were researched and left out to keep the list at twelve. Intellias has scale, with 3k+ AI-enabled engineers and a founding year of 2002 per its own pages, but no pharma page turned up and its life sciences page mentions GxP only in passing. HW.Tech, the software division of Helpware, has a substantial pharma page with AI dossier tooling but names no GxP framework or validation practice, and its LinkedIn and GoodFirms profiles describe the parent company rather than the division. Empeek's pharma page names FDA and ICH guidelines but no validation practice or named certificate. The one project it shows there is a workplace drug-testing data system for transportation and oil and gas companies, and its own site gives an Austin, Texas address without calling it headquarters, while LinkedIn names Leander, Texas.

Evaluation Criteria

These seven criteria are what a pharma QA, IT or procurement team should check with any company on this list, Pharos Production included. The weights, which add up to 50, show how much we think each one should count in your own evaluation, with evidence of GxP delivery at the top because a supplier audit starts there. The criteria did not order the list below, and no company on this page received a score against them. For how Pharos Production approaches the same questions in its own work, see its custom pharmaceutical software page.

Evidence of GxP delivery

10/10

Why it matters

A pharma QA team has to qualify the supplier before the software touches a GxP process. A delivered system that went through validation, described on the vendor's own pages, is the strongest evidence a buyer can check.

What to check

Ask for one GxP system the vendor built and the validation package that came with it, anonymized if necessary. Find out which GAMP 5 category it assumed for custom code and who executed the test scripts. Request a sample traceability matrix with client details removed.

Red flags

GxP named only inside a compliance list. No validated project the vendor will describe even without the client's name. Compliance offered as a guarantee rather than as documented, risk-based work that your QA team signs off.

Regulated-industry track record

8/10

Why it matters

A partner that already works under audits, quality agreements and change control needs less supervision on a GxP project. Years in life sciences, named regulated clients and certified quality systems are the parts of that history a buyer can check.

What to check

Establish how many projects the vendor ran for pharma, biotech or CRO clients, as distinct from healthcare providers. Get the certificate number, issuer and scope behind any ISO 13485 or ISO 27001 claim, along with a reference client that put the vendor through a supplier audit.

Red flags

A healthcare portfolio presented as pharma experience. Certification logos without scope or issuer. References only from unregulated projects.

AI under GxP

7/10

Why it matters

AI now reaches case intake, document drafting and quality review, all of them GxP-relevant work. A model inside a validated process needs logged inputs and outputs, a pinned version and a person who approves the record.

What to check

Ask how the vendor logs each model's inputs, outputs and version so an auditor can review them. Find out where a qualified person approves AI output before a record becomes final, and how the vendor re-tests after a model or prompt change.

Red flags

AI claims with no word on validation. A model writing to GxP records without human review. No answer on what happens when the model provider changes a version.

Integration breadth

7/10

Why it matters

Custom pharma software rarely stands alone. It reads from and writes to validated platforms for clinical data, safety, quality and ERP. Every one of those interfaces becomes a validation and change-control item.

What to check

Get the names of the clinical, safety, quality and ERP products the vendor has integrated. Ask how each interface is tested and how an upgrade on either side is regression-tested.

Red flags

System categories without a single named product. A plan to replace a validated platform where an integration would do. No regression plan for upgrades on the platform side.

EU and US regulatory coverage

7/10

Why it matters

A company selling medicines in both markets answers to FDA rules such as 21 CFR Part 11 and to EU GMP rules including Annex 11, with GDPR and, where it applies, HIPAA on the data side. A vendor fluent in only one set leaves the other to your QA team.

What to check

Check whether the vendor's own pages name both 21 CFR Part 11 and EU GMP Annex 11, and EMA as well as FDA. Ask how its data protection design differs between GDPR and HIPAA.

Red flags

Only HIPAA named on a page about drug development. No Annex 11 from a vendor pitching EU clients. Regulators listed with no mapping to controls.

Delivery model and time zones

6/10

Why it matters

Validation runs on reviews and sign-offs, so the hours a team shares with your QA and IT staff matter as much as its size. The engagement model also decides who owns code and documents.

What to check

Find out where the people who will write and test your code sit and how many working hours overlap with yours. Ask which engagement models the vendor offers and who will own the code, test evidence and documentation when the contract ends.

Red flags

A delivery location that changes between proposal and contract. No named technical lead. Documentation ownership missing from the contract.

Pricing transparency

5/10

Why it matters

Validation, integration and documentation can move a pharma budget far from a first estimate. A vendor that publishes ranges, rates or a priced discovery phase is easier to plan with.

What to check

Look for published ranges, rates or a priced discovery phase. Ask how the estimate splits between build, validation support and integration. Check the yearly maintenance cost as well.

Red flags

A single fixed price before discovery. No line for validation support. Rates that surface only after an NDA.

Top pharmaceutical software development companies

1 Pharos Production

Founded: 2013 (own about page)
Headcount: 90+ engineers, designers, product managers and compliance specialists (own about page)
Headquarters: Las Vegas, Nevada, with an engineering office in Kyiv, Ukraine (own about page)
Specialization: Custom software and AI engineering, with a regulated delivery record in healthcare

Pharos Production has no delivered pharma, biotech or CRO system among the more than 110 production applications it counts since 2013. Its closest evidence comes from healthcare. The CareConnect patient engagement platform was built as a secure layer on top of the client's existing clinical systems rather than as a replacement for them, per its own case study. On the MedCore EHR platform, compliance checks ran inside every sprint alongside the client's clinical and regulatory teams, and that case study reports a 100% audit pass rate across three annual HIPAA and GDPR assessments.

Its pharmaceutical software development page sets out the pharma offer: software built around a client's validated platforms rather than in place of them, and validation-ready delivery with the SDLC evidence a client's QA team reviews. Under that offer the client's QA team owns validation and signs it off, and Pharos Production does not sell validation execution. No Veeva, Salesforce or SAP partner status is claimed on its pages.

Pharos Production holds no ISO 27001 certificate and no SOC 2 report, per its contact page. On AI, its homepage says it declines projects where AI is mandated but would underperform deterministic logic, and argues that for well-defined business rules a rules engine outperforms an LLM at a hundredth of the cost with full auditability.

Every project has a named CTO-level lead, and the delivery method set out on the about page includes weekly client demos and written decision records. Clients own their source code from day one, per the same page. Its location pages say engineers align with US Eastern or Pacific time, with overlapping hours for standups, and the first reply to an inquiry comes within 24 hours. Engagements start with a paid discovery sprint of 2-4 weeks at $5,000-$15,000 that defines scope, architecture and a delivery plan, per its services page.

2 TTMS

Founded: 2015 (own about page, LinkedIn agrees)
Headcount: 786 employees (own timeline, 2023 entry), over 800 specialists and a 501-1,000 band per LinkedIn
Headquarters: Warsaw, Poland (own timeline, LinkedIn agrees)
Specialization: IT services with a pharma quality management and validation practice

TTMS, the brand of Transition Technologies MS S.A., sells computer system validation as a service line of its own. Its validation page names FDA, the UK's MHRA and EMA as the agencies that regulate such validation in pharma and says the work follows GAMP 5 and EU GMP Annex 11. The same page says the quality team is adopting Computer Software Assurance, while the pharma page describes validating a pharmaceutical company's SAP systems. The pages read do not name 21 CFR Part 11, although they do cite FDA regulations.

Its pharma page dates its pharma-sector work to 2011, before the company's founding year, and cites more than 400 specialists engaged and more than 100 projects and services supported since then. It names Takeda Pharma as the client of an AI system integrated with Salesforce CRM that assesses RFP criteria in tender processes, a commercial process rather than a GxP one. Adobe Experience Manager for portals aimed at healthcare professionals and SAP customer identity tooling also appear in its pharma work. Its about page lists ISO 42001, ISO 14001 and ISO 27001, and its pressroom says TÜV Nord Poland conducted the ISO/IEC 42001 audit of its AI management system.

TTMS offers three engagement levels: staff augmentation, team leasing and end-to-end delivery. Its timeline records nine locations in Poland and representative offices in the US and Singapore by 2019 and a delivery center in Bengaluru in 2023, and its LinkedIn text says centers on several continents let it work across time zones. No price or rate appears on its own pages or LinkedIn.

3 ScienceSoft

Founded: 1989 (own about page, LinkedIn agrees)
Headcount: 750+ IT professionals (own about page), LinkedIn band 501-1,000 employees
Headquarters: McKinney, Texas (LinkedIn, own about page says headquartered in the US)
Specialization: AI transformation and software development for healthcare, insurance and investment

On its life sciences page, ScienceSoft lists laboratory software, medical device software and clinical trial and R&D systems such as CTMS, and it states healthcare IT work since 2005 with 150+ successful projects in the domain. Its GxP evidence sits on its software compliance page, which shows a GAMP4-compliant system for cancer and TPN drug manufacturing built for a global pharma company and says the company writes validation plans aligned with FDA guidelines and GxP. Neither GAMP 5 nor Annex 11 appears on those two pages.

Its pages name FDA 21 CFR Part 11, HIPAA and the 21st Century Cures Act for the US and GDPR and the EU MDR and IVDR for the EU. The life sciences page adds GCP and GLP, and on AI it lists a pharmacovigilance AI engine that prepares MedDRA-coded reports among the use cases it says its life sciences clients find most impactful. It also states that each AI component it delivers runs within a validated sandbox, with explainable outputs and compliance audit trails. Integration evidence is standards-level, FHIR and HL7 plus clinical terminologies and DICOM, with no clinical or safety product named.

ScienceSoft's certifications page lists ISO 9001, ISO/IEC 27001, ISO/IEC 27701 and ISO 13485. The about page claims time zone coverage from GMT -9 to GMT +13, and LinkedIn lists offices in Texas, Finland, Latvia and the UAE among its locations. Published prices cover healthcare as a whole rather than pharma.

4 BGO LifeScience

Founded: 2008 (LinkedIn, GoodFirms agrees, own site gives only year counts)
Headcount: 130 employees (own contact page), LinkedIn band 51-200 employees
Headquarters: London, England (LinkedIn), own site lists London and Sofia without naming a headquarters, GoodFirms says Bulgaria
Specialization: Life sciences technology: data integrity and validation, agentic workflows and custom engineering

BGO LifeScience, still listed as BGO Software on GoodFirms, has a case study for a clinical data entry system built for a top-5 global CRO and delivered in compliance with FDA 21 CFR Part 11 and GMP. No other company on this list describes a validated system delivered for a contract research organization. Its GMP validated systems page says it helps pharma and biotech teams design, staff, validate and scale digital systems aligned with GAMP 5 and global GxP expectations.

The same page carries its AI position: agentic AI workflows that run validation work under CSV and GAMP 5 practice, and an agentic digital validation flow covering requirements, testing, changes, deviations and periodic review that it describes as compliant with 21 CFR Part 11 and Annex 11. Its certifications page labels ISO 9001:2015, ISO 13485:2016 and ISO/IEC 27001:2017 as certified and states an EU GMP certification, with no certificate number, issuer or scope given for any of them.

Databricks, through a partnership, is the only integration product it names, while LIMS, EDC and CTMS appear as system types rather than products.

5 Arkenea

Founded: 2011 (LinkedIn, own pharma page dates its healthcare-only work to 2011)
Headcount: 11-50 employees (LinkedIn band, own pages state none)
Headquarters: Cary, North Carolina (LinkedIn)
Specialization: Healthcare-only software development, marketed to pharma for validated, HIPAA-compliant systems

Of the companies here that describe no delivered GxP work, Arkenea sets out its validation method in the most detail. Its pharma page says HIPAA Security Rule safeguards and 21 CFR Part 11 requirements are decided at the data model stage and that discovery produces a validation approach before the build. A GAMP 5 risk assessment then sets validation depth per function under the FDA's Computer Software Assurance guidance, per the same page. The page also shows three named client cases: enterprise sales applications for physician engagement at Novo Nordisk, a clinical trial reporting and coordination platform for Medimergent and pharmaceutical dispensing software for Welgo, a US drug distributor. None of the three is described as a validated system.

On AI, the pharma page says features are built inside validated systems, with model inputs, outputs and versions logged and reviewable. Its FAQ says AI can be used inside a validated pharmaceutical system when a qualified person reviews and approves the output before the record is final. Ten named products make up its integration list, from Veeva Vault, Veeva CRM, Medidata Rave and Oracle Argus on the clinical and safety side to SAP S/4HANA, Oracle NetSuite, Dynamics 365, Salesforce, Salesforce Health Cloud and Epic among enterprise and EHR systems.

Its prices are published by tier, from a single module to a validated multi-system platform. LinkedIn lists a single location. Annex 11 does not appear on its pharma page, so its EU coverage stops at submission to EMA's EudraVigilance, and the pages read disclose no certification.

6 Innowise

Founded: 2007 (own about page, GoodFirms agrees, LinkedIn says 2017)
Headcount: 3,500+ employees (own about page, 2025 timeline entry), 50+ pharma software developers
Headquarters: Warsaw, Poland (own about page, LinkedIn and GoodFirms agree)
Specialization: Custom software development and outsourcing, with an in-house pharma team

Innowise's pharma page says it plans development around FDA 21 CFR Part 11, GxP, HIPAA and GDPR. It also says it implements GxP-compliant software with a validation process that includes IQ, OQ and PQ. The page names EMA next to FDA and describes a 100% in-house pharma team. GAMP 5, Annex 11 and CSA do not appear there, so the method behind its IQ, OQ and PQ steps is not described.

Its certifications page lists ISO 9001:2015, ISO 27001:2022 and ISO 13485:2016, but the ISO 13485 certificate file offered no readable text, so its scope could not be checked. The pharma page also guarantees that the software will adhere to 21 CFR Part 11, EMA, HIPAA and GDPR requirements, a promise to test in contract language, because accountability for a validated GxP system stays with the regulated company. For integration it names SAP for ERP and Microsoft Dynamics 365, Veeva and Salesforce for CRM, and its AI claims cover drug discovery with HPC, ML and deep learning rather than AI inside validated systems.

Its about page describes a distributed model across 20+ countries. Instead of a published range it promises a cost estimate for each project stage, with timelines of 3 to 6 months for smaller projects and 9 to 12+ months for larger ones.

7 ELEKS

Founded: 1991 (LinkedIn and GoodFirms, site footer runs from 1991)
Headcount: 2,000+ specialists (own about page, nearshore talent pool), LinkedIn band 1,001-5,000 employees
Headquarters: Tallinn, Estonia (own about page, LinkedIn and GoodFirms agree)
Specialization: Engineering and data services, with healthtech among its specialties

ELEKS states that its pharma solutions adhere to GxP requirements, GDPR and HIPAA and that its teams follow strict validation protocols throughout development. The same page says its pharmaceutical solutions align with FDA, EMA and ICH guidelines for each client's regulatory requirements. It does not name 21 CFR Part 11, Annex 11 or GAMP 5, so the validation method behind those statements is not visible.

Its pharma page shows a case on knowledge transfer and support for a pharma company's IT infrastructure, covering 30+ software solutions and 300+ servers. It lists the system types it builds for pharma companies, among them ERP, CTMS, QMS, LIMS, EDC and RIM, without naming a third-party product. On AI, it offers machine learning and intelligent automation for production scheduling and resource allocation while maintaining cGMP quality standards, with no statement on how the AI itself is validated.

Its certifications include HITRUST e1, announced in January 2025 for its processes and solutions, plus ISO 9001:2015, ISO/IEC 27001:2022 and SOC 2 Type II, with Cyber Essentials and Cyber Essentials Plus held by ELEKS UK Limited. Delivery runs through a development center in Lviv and a nearshore model.

8 Velvetech

Founded: 2004 (own about page, LinkedIn and GoodFirms agree)
Headcount: 150+ professionals by the end of 2023 (own about page), LinkedIn band 201-500 employees
Headquarters: Sunny Isles Beach, Florida (own contact page, LinkedIn agrees)
Specialization: Custom software, with pharma systems from R&D to post-market surveillance

Velvetech's pharma page names a long list of standards: 21 CFR Parts 11, 210, 211, 312 and 314, GAMP 5, ICH-GCP, DSCSA, USP, HL7, FHIR, CDISC, HIPAA, HITECH and the NIST Cybersecurity Framework. It says it follows computer system validation practices to keep systems audit-ready. Its catalog spans clinical systems from EDC and eTMF to ePRO and eCOA, along with manufacturing and quality software that digitizes batch records and manages deviations. Regulatory systems in the same catalog include Part 11 document management and validation management.

The same page shows five case studies without naming a client: an IoT system for a cold chain logistics company, a biorepository management solution, a controlled substance ordering system for pharmacies, an online pharmacy platform and insurance verification software. For the controlled substance system it says every component was designed and validated to comply with state regulations and DEA requirements, and none of the five describes GxP validation. EMA is its only EU reference, and Annex 11 does not appear. Its AI claims in pharma run from AI and ML platforms for compound screening in R&D to predictive analytics in clinical trials and intelligent automation in manufacturing, and no ISO or security certification is disclosed on the pages read.

Its pharma page puts custom pharmaceutical software projects at $50,000 to $300,000+ on average. The contact page adds an office in Chicago, and the team has worked fully distributed since 2020, with people in the US, Turkey, Georgia, Bulgaria and Costa Rica among other places.

9 EffectiveSoft

Founded: 2003 (LinkedIn, GoodFirms agrees, own site gives only 23 years of engineering)
Headcount: 201-500 employees (LinkedIn band, own pages state none)
Headquarters: San Diego, California (LinkedIn, own site lists San Diego without labeling it)
Specialization: AI-enabled software engineering for healthcare, financial services and ISV/SaaS companies

According to EffectiveSoft's life sciences page, its systems meet GxP, FDA, EMA and validation requirements, and it builds risk management, validation and documentation practices into its work. Its engineers release the validated version of the software into production, per the same page, which also offers validation support after release to keep systems compliant. No GxP project turned up on the pages read, and 21 CFR Part 11, GAMP 5 and Annex 11 do not appear.

Its technology list names Dynamics 365, Salesforce, Adobe Commerce, SharePoint, ServiceNow, Power BI and SAP among enterprise platforms, and its LinkedIn page claims Microsoft, AWS and Oracle partner status. For laboratories it offers LIMS integration and electronic lab notebooks. Its AI claims cover real-time, predictive and automated analytics rather than AI inside validated systems.

A certification page shows ISO/IEC 27001:2022 for both EffectiveSoft Corp. and EffectiveSoft Poland with CERT International as the issuer, and it lists GDPR, CMMI, HIPAA and CCPA under a compliance heading. The contact page lists offices in San Diego, San Francisco, Warsaw and San Jose in Costa Rica, and nearshore development is one of its delivery models.

10 Avenga

Founded: 2019 (GoodFirms only, own pages state no year, LinkedIn shows none)
Headcount: 6,000+ experts (own about page), LinkedIn band 5,001-10,000 employees
Headquarters: Prague, Czechia (LinkedIn, GoodFirms says United States, own pages state none)
Specialization: Broad digital engineering with a life sciences practice

Avenga organizes its life sciences page around three R&D lines, discovery and preclinical, digital clinical trials and drug safety, plus a commercialization practice where it says 300+ pharma organizations use solutions it built. It describes its work as supporting alignment with 21 CFR Part 11, HIPAA and EU Annex 11 and with CDISC, ICH E2B and HL7 FHIR as industry standards. GxP, GAMP 5, CSV and CSA do not appear on the page, and it describes no validation deliverable.

AI appears in drug safety, where it says AI and automation cut manual pharmacovigilance work, and in clinical and research data analysis, with no statement about AI inside validated systems. It names Microsoft, AWS and Salesforce as partners through which it delivers ERP, CRM and compliance tools for pharma clients.

Its about page lists offices in 18 countries, 14 of them in Europe, and its pharma page says its teams work within the client's time zone and claims 30+ years of delivery. No price or certification appears on the pages read.

11 Andersen

Founded: 2007 (LinkedIn, own about page states 19 years of experience)
Headcount: 3,500+ in-house experts (own about page), LinkedIn band 1,001-5,000 employees
Headquarters: Warsaw, Poland (own about page, LinkedIn agrees)
Specialization: Generalist custom software development and consulting

Andersen's pharma page covers clinical trial management tools, patient engagement platforms, pharmacovigilance software and inventory, warehouse and distribution software with recall management. It claims compliance with GMP and GPP standards for its distribution and production modules. Neither 21 CFR Part 11 nor Annex 11 appears on the pharma page, and GAMP 5 and EMA are absent as well.

Its life science page says its quality management system is certified to ISO 9001, ISO 27001 and ISO 13485 without stating a scope, and the certificates page names no standard in its text. Integration is described only as integrating platforms for clinical trials, with no product named. On AI, the pharma page lists AI-based software for clinical decision support among its MedTech offerings. GDPR and HIPAA are the data protection rules it names.

Its about page lists 18 office locations, with development centers in Krakow and Munich among them. No price, rate or range was found.

12 ITRex

Founded: 2009 (LinkedIn, GoodFirms agrees)
Headcount: 250+ professionals (own about page), LinkedIn band 201-500 employees
Headquarters: Aliso Viejo, California (LinkedIn, GoodFirms says United States)
Specialization: AI-first engineering, from machine learning to agentic and generative AI

ITRex presents itself as AI-first, and its LinkedIn specialties run from AI and ML through RAG to agentic and generative AI and LLMOps. Its pharma page says it deploys retrieval-augmented generation to eliminate hallucinations and builds AI agents that analyze clinical data, generate research summaries, automate regulatory reporting and monitor manufacturing quality in real time. The same site sells AI model validation and EU AI Act compliance services.

None of the three pages read, its pharma, life science and AI model validation pages, names GxP, GMP, 21 CFR Part 11 or GAMP 5, and its AI services are not tied to GxP validation anywhere in that text. The pharma page positions the company as audit-ready and names FDA, EMA and ICH standards in an FAQ answer. It claims a decade of delivery across healthcare, pharma, biotech and life sciences and states HIMSS Emerald membership.

Its about page lists two offices, in Warsaw and in Aliso Viejo, California. The pages read name no third-party integration product, and their only price is for AI model validation, where a one-time audit for a specific compliance risk such as bias typically costs $20,000 to $50,000.

Pharma IT companies at a glance

Rank	Company	Founded	Headcount	HQ	Specialization
1	Pharos Production	2013 (own about page)	90+ engineers, designers, product managers and compliance specialists (own about page)	Las Vegas, Nevada, with an engineering office in Kyiv, Ukraine (own about page)	Custom software and AI engineering, with a regulated delivery record in healthcare
2	TTMS	2015 (own about page, LinkedIn agrees)	786 employees (own timeline, 2023 entry), over 800 specialists and a 501-1,000 band per LinkedIn	Warsaw, Poland (own timeline, LinkedIn agrees)	IT services with a pharma quality management and validation practice
3	ScienceSoft	1989 (own about page, LinkedIn agrees)	750+ IT professionals (own about page), LinkedIn band 501-1,000 employees	McKinney, Texas (LinkedIn, own about page says headquartered in the US)	AI transformation and software development for healthcare, insurance and investment
4	BGO LifeScience	2008 (LinkedIn, GoodFirms agrees, own site gives only year counts)	130 employees (own contact page), LinkedIn band 51-200 employees	London, England (LinkedIn), own site lists London and Sofia without naming a headquarters, GoodFirms says Bulgaria	Life sciences technology: data integrity and validation, agentic workflows and custom engineering
5	Arkenea	2011 (LinkedIn, own pharma page dates its healthcare-only work to 2011)	11-50 employees (LinkedIn band, own pages state none)	Cary, North Carolina (LinkedIn)	Healthcare-only software development, marketed to pharma for validated, HIPAA-compliant systems
6	Innowise	2007 (own about page, GoodFirms agrees, LinkedIn says 2017)	3,500+ employees (own about page, 2025 timeline entry), 50+ pharma software developers	Warsaw, Poland (own about page, LinkedIn and GoodFirms agree)	Custom software development and outsourcing, with an in-house pharma team
7	ELEKS	1991 (LinkedIn and GoodFirms, site footer runs from 1991)	2,000+ specialists (own about page, nearshore talent pool), LinkedIn band 1,001-5,000 employees	Tallinn, Estonia (own about page, LinkedIn and GoodFirms agree)	Engineering and data services, with healthtech among its specialties
8	Velvetech	2004 (own about page, LinkedIn and GoodFirms agree)	150+ professionals by the end of 2023 (own about page), LinkedIn band 201-500 employees	Sunny Isles Beach, Florida (own contact page, LinkedIn agrees)	Custom software, with pharma systems from R&D to post-market surveillance
9	EffectiveSoft	2003 (LinkedIn, GoodFirms agrees, own site gives only 23 years of engineering)	201-500 employees (LinkedIn band, own pages state none)	San Diego, California (LinkedIn, own site lists San Diego without labeling it)	AI-enabled software engineering for healthcare, financial services and ISV/SaaS companies
10	Avenga	2019 (GoodFirms only, own pages state no year, LinkedIn shows none)	6,000+ experts (own about page), LinkedIn band 5,001-10,000 employees	Prague, Czechia (LinkedIn, GoodFirms says United States, own pages state none)	Broad digital engineering with a life sciences practice
11	Andersen	2007 (LinkedIn, own about page states 19 years of experience)	3,500+ in-house experts (own about page), LinkedIn band 1,001-5,000 employees	Warsaw, Poland (own about page, LinkedIn agrees)	Generalist custom software development and consulting
12	ITRex	2009 (LinkedIn, GoodFirms agrees)	250+ professionals (own about page), LinkedIn band 201-500 employees	Aliso Viejo, California (LinkedIn, GoodFirms says United States)	AI-first engineering, from machine learning to agentic and generative AI

Published prices and cost drivers

Two companies on this list publish project prices for pharma work. Arkenea's pharma page puts an initial build at $75,000 to $350,000. A single module such as an adverse event intake tool runs $75,000 to $120,000, while a multi-system platform with full GAMP 5 validation runs $220,000 to $350,000 and above. Annual maintenance adds 15 to 20 percent of the build cost. Velvetech's pharma page says custom pharmaceutical software projects range from $50,000 to $300,000+ on average.

ScienceSoft publishes ranges for healthcare as a whole rather than for pharma, starting at $60,000 to $100,000 for a simple patient or staff mobile app, and offers a free, non-binding estimate. ITRex's AI model validation page puts a one-time audit for a specific compliance risk such as bias at $20,000 to $50,000. For five companies the only public price is an hourly band on GoodFirms. ELEKS and BGO LifeScience sit at $25 to $49, while Avenga, Innowise and EffectiveSoft sit at $50 to $99, the band GoodFirms also lists for Velvetech and ITRex. No rate or range was found for TTMS or Andersen.

Pharos Production does not publish a pharma-specific range. Every engagement starts with a paid discovery sprint of 2-4 weeks at $5,000-$15,000 that defines scope, architecture and a delivery plan, per its services page. The drivers that move a pharma estimate can be checked in any vendor's quote: the GAMP 5 category assumed for each component, the number of validated systems the software connects to, how much validation support the contract includes, how much data has to migrate and whether AI output needs its own evaluation set.

Treat every figure here as a starting point for a first call, not as a quote. Published ranges rarely say how much validation effort they include, so ask each vendor to split its estimate between build, validation support and integration before you compare totals.

How to use this list

The facts block in each entry answers a screening question. It does not tell you whether a company can deliver a system your QA team will sign off, and a 130-person specialist can be the right partner where a 6,000-person generalist is not.

Use the seven criteria as questions. Take the two or three companies whose entries match the system you need and ask each for one GxP system it delivered, with the validation package that came with it. Then compare the answers with what its own pages claim, and put any gap between the two on the agenda for the supplier audit.

A headquarters city says little about where the work happens, since several companies here deliver from offices or distributed teams in other countries. Ask which office will staff your project before the contract names one.

How Pharos Production answers these seven criteria

Evidence of GxP delivery

No delivered pharma, biotech or CRO system. Its pharmaceutical software development page offers validation-ready delivery with SDLC evidence, and the client's QA team owns validation and its sign-off.

Regulated-industry track record

Healthcare rather than pharma, with the CareConnect patient engagement platform and the MedCore EHR platform, whose case study reports a 100% audit pass rate across three annual HIPAA and GDPR assessments.

AI under GxP

No GxP AI case. Its homepage says it declines projects where AI is mandated but would underperform deterministic logic, arguing that a rules engine outperforms an LLM on well-defined rules at a hundredth of the cost with full auditability.

Integration breadth

Its pharmaceutical software development page describes software built around a client's validated platforms rather than in place of them, and the CareConnect case study describes a secure layer on top of a client's existing clinical systems. No Veeva, Salesforce or SAP partner status is claimed.

EU and US regulatory coverage

No delivered work under 21 CFR Part 11 or EU GMP Annex 11. The MedCore case study covers HIPAA and GDPR. Pharos Production holds no ISO 27001 certificate and no SOC 2 report, per its contact page.

Delivery model and time zones

A named CTO-level lead on every project and a delivery method with weekly client demos and written decision records, per its about page. Its location pages say engineers align with US Eastern or Pacific time for standups, and the first reply to an inquiry comes within 24 hours.

Pricing transparency

Every engagement starts with a paid discovery sprint of 2-4 weeks, priced on its services page, that defines scope, architecture and a delivery plan. Its homepage says it declines fixed-price contracts without discovery validation.

Decision Checklist

Before the first call

Name the GxP processes the software will touch and the regulations behind them
List every validated system it must read from or write to
Decide who in your QA team owns validation and signs the final report
Set a budget range that covers validation support as well as the build

During evaluation

Request one delivered GxP system and its validation package, anonymized if needed
Check that the vendor's pages name both 21 CFR Part 11 and EU GMP Annex 11
Get the certificate number, issuer and scope behind every ISO claim
Ask how AI output is logged, versioned and approved before a record is final
Compare engagement models and the working hours your teams would share

Before signing

Agree a quality agreement that splits supplier and client validation duties
Confirm the supplier audit scope and the SDLC evidence you will receive
Put ownership of code, test evidence and documents into the contract
Agree how change control works after go-live

FAQ

Start with evidence of GxP delivery: one system the partner built that went through validation, with the validation package that came with it. Then check its regulated-industry record, how it controls AI inside validated processes, which platforms it has integrated by name, whether it covers both FDA and EU GMP rules, how many working hours it shares with your QA team and how openly it prices.

The companies on this list describe several. TTMS names three levels of engagement: staff augmentation, team leasing and end-to-end delivery. EffectiveSoft lists nearshore agile development, IT staff augmentation and dedicated teams as its ways of working. Innowise's LinkedIn specialties include dedicated development centers and software outsourcing, and Arkenea fixes scope and price against a document produced in discovery. Pharos Production opens every engagement with a paid discovery sprint, then runs fixed-price projects for well-specified work or dedicated team and staff augmentation models for ongoing development, per its services page.

Not in the product sense: this page covers companies that build custom software, integrations and AI layers for pharma clients, not vendors of licensed pharma platforms. In the search sample behind this page, half of the lists for a similar query ranked licensed products instead.

Because the publisher placed it there, as the disclosure at the top of the page states, and the order of the other eleven is an editorial reading of their own pages rather than a score. Pharos Production's entry states its main gap, which is that it has no delivered pharma, biotech or CRO system and that its regulated delivery record is in healthcare.

Partly. Healthcare work under HIPAA builds habits that carry over, such as audit logs, role-based access and interoperability with the clinical systems around them. GxP adds duties that healthcare projects rarely carry: predicate rules, computer system validation or computer software assurance, supplier audits and change control over a validated state. Pharos Production's own record sits on the healthcare side of that line. Several other companies here also present healthcare-wide records, such as ScienceSoft's healthcare IT work since 2005 and Arkenea's healthcare-only focus since 2011, so ask each which of its projects were for pharma clients.

Arkenea and Velvetech publish pharma project ranges on their own pages: $75,000 to $350,000 for an initial build at Arkenea and $50,000 to $300,000+ on average at Velvetech. ScienceSoft prices healthcare work as a whole, Pharos Production publishes the price of its paid discovery sprint and five others show only a GoodFirms hourly band.

An ISO certificate shows that a management system was audited against a standard within the scope printed on the certificate. It does not validate a GxP system, because validation happens system by system and is accepted by the regulated company. Several companies here name certificates without a scope or issuer, and BGO LifeScience states an EU GMP certification without a certificate number, so ask for the certificate itself before relying on a logo. Pharos Production holds no ISO 27001 certificate and no SOC 2 report, per its contact page.

All three were researched and left out to keep the list at twelve. No pharma page turned up for Intellias, HW.Tech's pharma page names no GxP framework or validation practice and Empeek's pharma page names FDA and ICH guidelines without a validation practice.